Compound details
Rocaglamide
| Compound ID | CDAMM00440 |
|---|---|
| Common name | Rocaglamide | IUPAC name | 1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-2,3-dihydro-1H-cyclopenta[b][1]benzofuran-2-carboxamide |
| Molecular formula | C29H31NO7 |
| Retention time | 0.31 |
|---|---|
| Adduct | [M+K]+ |
| Actual mz | 544.179 | Theoretical mz | 544.173 |
| Error | 10.37 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 5.5401 |
| Inchi key | DAPAQENNNINUPW-AMVGUFJQNA-N |
|---|---|
| Smiles | O=C(N(C)C)C1C(O)C2(O)C=3C(OC)=CC(OC)=CC3OC2(C4=CC=C(OC)C=C4)C1C=5C=CC=CC5 |
| Superclass | Organoheterocyclic compounds |
| Class | Benzofurans |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P08183 | ABCB1 | P-glycoprotein 1 | T25258 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P25101 | EDNRA | Endothelin receptor ET-A | T23499 | SEA |
| P16109 | SELP | P-selectin | T10965 | SEA |
| P24530 | EDNRB | Endothelin receptor ET-B | T92828 | SEA |
| P60842 | EIF4A1 | Eukaryotic initiation factor 4A-I | T86805 | SEA |
| P47901 | AVPR1B | Vasopressin V1b receptor | T59881 | SEA |
| Q7RTX1 | TAS1R1 | Taste receptor | T41263 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T25258 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08183 | ABCB1 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T23499 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P25101 | EDNRA |
| T23499 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P25101 | EDNRA |
| T23499 | DI0425 | Urinary system clinical symptom | [ICD-11: MF8Y] | P25101 | EDNRA |
| T10965 | DI0088 | Circulatory system disease | [ICD-11: BE2Z] | P16109 | SELP |
| T10965 | DI0381 | Sickle-cell disorder | [ICD-11: 3A51] | P16109 | SELP |
| T92828 | DI0070 | Cardiovascular disease | [ICD-11: BA00-BE2Z] | P24530 | EDNRB |
| T92828 | DI0356 | Pulmonary hypertension | [ICD-11: BB01] | P24530 | EDNRB |
| T86805 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P60842 | EIF4A1 |
| T59881 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | P47901 | AVPR1B |
| T59881 | DI0041 | Autism spectrum disorder | [ICD-11: 6A02] | P47901 | AVPR1B |
| T59881 | DI0194 | Hypo-osmolality/hyponatraemia | [ICD-11: 5C72] | P47901 | AVPR1B |
| T41263 | DI0078 | Cholera | [ICD-11: 1A00] | Q7RTX1 | TAS1R1 |